Abstract:Cannabis use is prevalent among youth with mental illness, despite the increased risk of exacerbating psychiatric symptoms. The rapidly changing legality of cannabis has contributed to its normalization and decreased perceived risks. This study qualitatively gathered young adult psychiatric patients’ ( n=15) perspectives on cannabis to inform a use reduction intervention. NVivo12 was used to organize coded data and facilitate analysis. Motivations to use included viewing cannabis utilization as normalized, sup… Show more
“…I feel if I take the medications I'll just progressively change and not be myself.(Whiteley et al, 2021)…”
Section: Resultsmentioning
confidence: 99%
“…The quantitative studies (Bizzarri et al, 2007; Bolton et al, 2009; Lorberg et al, 2010; Meyer et al, 2012; Sonne et al, 1994; Tyler et al, 2015; Weiss, 2004; Weiss et al, 1992) used a variety of self‐report measures (see Table 1). The qualitative studies (Brown & Stewart, 2008; Canham et al, 2018; Castaneda, 2020; Cornford et al, 2012; Healey et al, 2009; Newman et al, 2012; Ward, 2011; Whiteley et al, 2021) mostly used qualitative interviews combined with thematic analysis. The two case series papers (Grinspoon & Bkalar, 1998; Gruber et al, 1996) reported on 7 and 5 cases, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…A sense of loss of control associated with decision‐making and possible effects of prescribed drugs was also a concern to some.I feel if I take the medications I'll just progressively change and not be myself.(Whiteley et al, 2021)…”
Section: Resultsmentioning
confidence: 99%
“…I feel if I take the medications I'll just progressively change and not be myself. (Whiteley et al, 2021) Many participants used substances in the face of ineffective prescribed treatments, and a desire for a more natural, less potentially harmful substance; however, the illicit status of many drugs posed access and ethical problems for some participants.…”
Section: More Effective Than Prescribed Medicationsmentioning
Accessible Summary
What is known on the subject?
People with mood disorders often use substances.
There are several clinician‐driven hypotheses explaining the relationship.
What the paper adds to existing knowledge?
The paper draws together the existing research on the perceptions of those with lived experience of mood disorders on the reasons for using substances.
The participants in the studies identified using substances to manage their mood when treatment to manage their mood was not effective or acceptable, and as an escape from trauma and hardship.
What are the implications for practice?
Mental health nurses need an understanding of why people with mood disorders may use substances and the impact of this on their treatment.
Mental health nurses need to provide trauma‐informed care that emphasizes harm reduction for those who have mood disorders and substance use.
Abstract
IntroductionSubstance use is highly prevalent among people with mood disorders. Effective treatment for these people requires a better understanding of the relationship between both mood and substance use from the perspectives of those with lived experience.
QuestionWhat are the reasons those with lived experience of mood disorders give for substance use?
MethodAn integrative review was conducted. The Joanna Briggs Institute suite of critical appraisal tools was used to evaluate the quality of individual studies. Data relevant to the review question were extracted, and the results were synthesized into themes.
ResultsEighteen papers met the eligibility criteria. Three themes were identified across the included studies: Managing my mood, More Effective than prescribed medication, and Escape from trauma and hardship.
DiscussionThis integrative review identified that people with a mood disorder who use substances described choosing to take substances to manage their mood, as an alternative to prescribed medications, and to cope with trauma and social hardships.
Implications for PracticeMental health nurses need to provide care that recognizes why people use substances. They need to understand these reasons to provide a harm reduction and trauma‐informed model of care. Evidence‐based non‐pharmacological interventions for mood disorders need to be available as an alternative to medications or as a supplement.
“…I feel if I take the medications I'll just progressively change and not be myself.(Whiteley et al, 2021)…”
Section: Resultsmentioning
confidence: 99%
“…The quantitative studies (Bizzarri et al, 2007; Bolton et al, 2009; Lorberg et al, 2010; Meyer et al, 2012; Sonne et al, 1994; Tyler et al, 2015; Weiss, 2004; Weiss et al, 1992) used a variety of self‐report measures (see Table 1). The qualitative studies (Brown & Stewart, 2008; Canham et al, 2018; Castaneda, 2020; Cornford et al, 2012; Healey et al, 2009; Newman et al, 2012; Ward, 2011; Whiteley et al, 2021) mostly used qualitative interviews combined with thematic analysis. The two case series papers (Grinspoon & Bkalar, 1998; Gruber et al, 1996) reported on 7 and 5 cases, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…A sense of loss of control associated with decision‐making and possible effects of prescribed drugs was also a concern to some.I feel if I take the medications I'll just progressively change and not be myself.(Whiteley et al, 2021)…”
Section: Resultsmentioning
confidence: 99%
“…I feel if I take the medications I'll just progressively change and not be myself. (Whiteley et al, 2021) Many participants used substances in the face of ineffective prescribed treatments, and a desire for a more natural, less potentially harmful substance; however, the illicit status of many drugs posed access and ethical problems for some participants.…”
Section: More Effective Than Prescribed Medicationsmentioning
Accessible Summary
What is known on the subject?
People with mood disorders often use substances.
There are several clinician‐driven hypotheses explaining the relationship.
What the paper adds to existing knowledge?
The paper draws together the existing research on the perceptions of those with lived experience of mood disorders on the reasons for using substances.
The participants in the studies identified using substances to manage their mood when treatment to manage their mood was not effective or acceptable, and as an escape from trauma and hardship.
What are the implications for practice?
Mental health nurses need an understanding of why people with mood disorders may use substances and the impact of this on their treatment.
Mental health nurses need to provide trauma‐informed care that emphasizes harm reduction for those who have mood disorders and substance use.
Abstract
IntroductionSubstance use is highly prevalent among people with mood disorders. Effective treatment for these people requires a better understanding of the relationship between both mood and substance use from the perspectives of those with lived experience.
QuestionWhat are the reasons those with lived experience of mood disorders give for substance use?
MethodAn integrative review was conducted. The Joanna Briggs Institute suite of critical appraisal tools was used to evaluate the quality of individual studies. Data relevant to the review question were extracted, and the results were synthesized into themes.
ResultsEighteen papers met the eligibility criteria. Three themes were identified across the included studies: Managing my mood, More Effective than prescribed medication, and Escape from trauma and hardship.
DiscussionThis integrative review identified that people with a mood disorder who use substances described choosing to take substances to manage their mood, as an alternative to prescribed medications, and to cope with trauma and social hardships.
Implications for PracticeMental health nurses need to provide care that recognizes why people use substances. They need to understand these reasons to provide a harm reduction and trauma‐informed model of care. Evidence‐based non‐pharmacological interventions for mood disorders need to be available as an alternative to medications or as a supplement.
“…Changes in cannabis legalization policies have contributed to the normalization of cannabis use, especially among young adults ( Hughes et al, 2015 ). Young adults often perceive cannabis as “natural” and less harmful than other substances; yet it can adversely affect brain function, particularly during the critical developmental stage of young adulthood ( Whiteley et al, 2021 ). Medical cannabis is currently legal in 38 states, four US territories, and the federal District of Columbia (DC); non-medical use is permitted in 23 states, three US territories, and DC ( McClure et al, 2023 , National Conference of State Legislatures, 2023 ).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
